UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 133 filers reported holding UNIQURE NV in Q1 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $613,146 | +4.4% | 91,378 | +78.3% | 0.00% | – |
Q2 2023 | $587,462 | -42.5% | 51,262 | +1.1% | 0.00% | – |
Q1 2023 | $1,021,400 | +255.5% | 50,715 | +300.2% | 0.00% | – |
Q4 2022 | $287,297 | -6.1% | 12,673 | -22.1% | 0.00% | – |
Q3 2022 | $306,000 | -24.1% | 16,275 | -24.9% | 0.00% | – |
Q2 2022 | $403,000 | +11.3% | 21,671 | +7.8% | 0.00% | – |
Q1 2022 | $362,000 | +15.7% | 20,094 | +32.9% | 0.00% | – |
Q4 2021 | $313,000 | -94.9% | 15,117 | -92.1% | 0.00% | -100.0% |
Q3 2021 | $6,113,000 | +974.3% | 190,983 | +933.5% | 0.00% | – |
Q2 2021 | $569,000 | -8.7% | 18,480 | -0.1% | 0.00% | – |
Q1 2021 | $623,000 | -57.2% | 18,506 | -54.0% | 0.00% | – |
Q4 2020 | $1,455,000 | +24.8% | 40,239 | +27.1% | 0.00% | – |
Q3 2020 | $1,166,000 | -12.2% | 31,657 | +7.5% | 0.00% | – |
Q2 2020 | $1,328,000 | -16.2% | 29,452 | -11.8% | 0.00% | -100.0% |
Q1 2020 | $1,585,000 | -59.4% | 33,390 | -38.7% | 0.00% | 0.0% |
Q4 2019 | $3,905,000 | +140.6% | 54,494 | +32.1% | 0.00% | – |
Q3 2019 | $1,623,000 | -5.9% | 41,259 | +78.8% | 0.00% | – |
Q2 2019 | $1,725,000 | +77.7% | 23,077 | +33.9% | 0.00% | – |
Q1 2019 | $971,000 | +96.6% | 17,239 | +0.7% | 0.00% | – |
Q4 2018 | $494,000 | -23.9% | 17,116 | -4.0% | 0.00% | – |
Q3 2018 | $649,000 | +19.7% | 17,829 | +24.2% | 0.00% | – |
Q2 2018 | $542,000 | +1053.2% | 14,357 | +617.8% | 0.00% | – |
Q1 2018 | $47,000 | +20.5% | 2,000 | 0.0% | 0.00% | – |
Q4 2017 | $39,000 | +105.3% | 2,000 | 0.0% | 0.00% | – |
Q3 2017 | $19,000 | +58.3% | 2,000 | 0.0% | 0.00% | – |
Q2 2017 | $12,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2017 | $12,000 | +9.1% | 2,000 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | -52.2% | 2,000 | -33.3% | 0.00% | – |
Q3 2016 | $23,000 | +53.3% | 3,000 | +50.0% | 0.00% | – |
Q2 2016 | $15,000 | -37.5% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $24,000 | -27.3% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $33,000 | -19.5% | 2,000 | 0.0% | 0.00% | – |
Q3 2015 | $41,000 | -24.1% | 2,000 | 0.0% | 0.00% | – |
Q2 2015 | $54,000 | +125.0% | 2,000 | +100.0% | 0.00% | – |
Q1 2015 | $24,000 | +242.9% | 1,000 | +100.0% | 0.00% | – |
Q4 2014 | $7,000 | +133.3% | 500 | +66.7% | 0.00% | – |
Q3 2014 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
Q2 2014 | $4,000 | -20.0% | 300 | -7.7% | 0.00% | – |
Q1 2014 | $5,000 | – | 325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |